FDA Approves New Indication for Envarsus XR (tacrolimus extended-release tablets)

COPENHAGEN, Denmark, Dec. 19, 2018 /PRNewswire/ -- Veloxis Pharmaceuticals announced today that the U.S. Food& Drug Administration (FDA) approved a new indication for Envarsus XR (tacrolimus extended-release tablets) to prevent organ rejection...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news